Share
Journal Information
Most often read
606
“Methodological notes”: a new and important section in Clínica e Investigación en ArteriosclerosisJosep Ribalta, Carlos Lahoz, Xavier Pintó
Clin Investig Arterioscler. 2023;35:243
606
Full text access
Open Article
492
Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primerMaría A. Zuriaga, José J. Fuster
Clin Investig Arterioscler. 2023;35:35-41
492
Open Article
490
Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD studyAntonio Ruiz-Garcia, Ezequiel Arranz-Martínez, Nerea Iturmendi-Martínez, Teresa Fernández-Vicente, Montserrat Rivera-Teijido, Juan Carlos García-Álvarez
Clin Investig Arterioscler. 2023;35:64-74
490
Open Article
471
Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV studyElena M. Yubero-Serrano, Francisco M. Gutiérrez-Mariscal, Purificación Gómez-Luna, Juan F. Alcalá-Diaz, Pablo Pérez-Martinez, José López-Miranda
Clin Investig Arterioscler. 2023;35:105-14
471
Open Article
468
Pemafibrate: PROMINENT failure or an urgent need for therapeutic replacement?Juan Carlos Laguna Egea, Núria Roglans Ribas, Roger Bentanachs Raset
Clin Investig Arterioscler. 2023;35:202-5
468
Full text access
Open Article
458
Absence of the influence of the APOE gene on the incidence of type 2 diabetes mellitus in a cohort of workers: Effect of diet and shift workRocío Mateo-Gallego, Sofía Pérez-Calahorra, Ana M. Bea, Irene Gracia-Rubio, Carmen Rodrigo-Carbo, Belen Moreno-Franco, Fernando Civeira, Martín Laclaustra, Itziar Lamiquiz-Moneo
Clin Investig Arterioscler. 2023;35:226-35
458
Open Article
409
Vascular smooth muscle cell aging: Insights from Hutchinson-Gilford progeria syndromeMagda R. Hamczyk, Rosa M. Nevado
Clin Investig Arterioscler. 2023;35:42-51
409
Open Article
394
Remnant cholesterol, vascular risk, and prevention of atherosclerosisXavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán
Clin Investig Arterioscler. 2023;35:206-17
394
Open Article
364
The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysisJose A. Quesada, Vicente Bertomeu-González, Domingo Orozco-Beltrán, Alberto Cordero, Vicente F. Gil-Guillén, Adriana López-Pineda, Rauf Nouni-García, Concepción Carratalá-Munuera
Clin Investig Arterioscler. 2023;35:165-77
364
Open Article
333
A case of hypocholesterolemia under researchAna Camacho, María José Ariza, Nuria Amigó, Patricia Macías Guillén, Miguel Ángel Sánchez Chaparro, Pedro Valdivielso
Clin Investig Arterioscler. 2023;35:244-7
333
Full text access
Open Article
313
Health-related lifestyle assessment among Spanish adults from 22 to 72 yearsPedro Luis Rodríguez García, Juan José Pérez Soto, Eliseo García Cantó, Marcos Meseguer Zafra, Raúl Salmerón Ríos, Pedro Juan Tárraga López
Clin Investig Arterioscler. 2023;35:12-20
313
Open Article
311
Arterial ageing and atherosclerotic risk: new perspectivesVicente Lahera Juliá, Ana M. Lahera García
Clin Investig Arterioscler. 2023;35:32-4
311
Open Article
306
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptorSusana Martín-Vañó, Alejandra Miralles-Abella, Pascual Castaño, Gema Hurtado-Genovés, María Aguilar-Ballester, Andrea Herrero-Cervera, Angela Vinué, Sergio Martínez-Hervás, Herminia González-Navarro
Clin Investig Arterioscler. 2023;35:1-11
306
Full text access
Open Article
304
Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023Pablo Pérez-Martínez, Emilio Ros, Juan Pedro-Botet, Fernando Civeira, Vicente Pascual, Carmen Garcés, Rosa Solá, Francisco Pérez-Jiménez, José M. Mostaza
Clin Investig Arterioscler. 2023;35:248-61
304
Open Article
281
Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI StudyÀlex Vila, Estel Pons, Patricia Trinidad García, Daniel Vidal, Sara López, Armand Grau
Clin Investig Arterioscler. 2023;35:272-9
281
Full text access
Open Article
263
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS studyAgustín Blanco Echevarría, Juan De Dios García Díaz, Assumpta Caixas, Núria Plana Gil, Miguel Ángel Rico Corral, Ian Bridges, Nafeesa Dhalwani, Sònia Gatell Menchen, Kausik K. Ray
Clin Investig Arterioscler. 2023;35:263-71
263
Full text access
Open Article
262
Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast MexicoValeria Ovando Gómez, Soraya Amalí Zavaleta Muñiz, Héctor Ochoa-Díaz-López, José Armando Camilo Hernández Contreras, Cesar Antonio Irecta Nájera
Clin Investig Arterioscler. 2023;35:53-63
262
Open Article
245
Consensus document for lipid profile determination and reporting in Spanish clinical laboratoriesTeresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruiz, Manuel Rodríguez Piñero, José Francisco Valderrama Marcos, Antonio Pérez Pérez, Manuel Antonio Botana López, Ana Morais López, ... en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular
Clin Investig Arterioscler. 2023;35:91-100
245
Full text access
Open Article
243
Nutritional recommendations in the prevention and treatment of atherogenic dyslipidemiaVicente Pascual, José Luis Díaz, Jesús Millán Nuñez-Cortés, Pablo Pérez-Martínez
Clin Investig Arterioscler. 2023;35:155-63
243
Open Article
234
Cardiovascular risk factors and death in South AmericaPatricio López-Jaramillo, José P. López-López
Clin Investig Arterioscler. 2023;35:195-200
234
Open Article